MedTrace Logo

Effect of Nifedipine GITS in Patients With Mild-to-moderate Primary Hypertension

NCT02641821 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 700

Last updated 2019-03-22

No results posted yet for this study

Summary

This is a multi-center, open-label, observational study. The aim of this study is to evaluate the efficacy of Nifedipine GITS on lowering blood pressure in Chinese adults with mild-to-moderate hypertension.

Conditions

Interventions

DRUG

Nifedipine GITS

Sponsors & Collaborators

  • Bayer

    collaborator INDUSTRY

  • Peking University First Hospital

    lead OTHER

Principal Investigators

  • Yong Huo, MD · Peking University First Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02641821 on ClinicalTrials.gov